These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

644 related items for PubMed ID: 7558710

  • 21. Interleukin-1 receptor antagonist therapy and induction of anterior chamber-associated immune deviation-type tolerance after corneal transplantation.
    Yamada J, Zhu SN, Streilein JW, Dana MR.
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4203-8. PubMed ID: 11095616
    [Abstract] [Full Text] [Related]

  • 22. Correlation of anterior chamber-associated immune deviation with suppression of corneal epithelial rejection in mice.
    Yao YF, Inoue Y, Miyazaki D, Hara Y, Shimomura Y, Tano Y, Ohashi Y.
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):292-300. PubMed ID: 9040461
    [Abstract] [Full Text] [Related]

  • 23. Effect of cyclosporine on anterior chamber-associated immune deviation with retinal transplantation.
    Ishioka M, Okamoto S, Streilein JW, Jiang LQ.
    Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2152-60. PubMed ID: 9331279
    [Abstract] [Full Text] [Related]

  • 24. The critical role of lymph nodes in corneal alloimmunization and graft rejection.
    Yamagami S, Dana MR.
    Invest Ophthalmol Vis Sci; 2001 May; 42(6):1293-8. PubMed ID: 11328742
    [Abstract] [Full Text] [Related]

  • 25. Increase in orthotopic murine corneal transplantation rejection rate with anterior synechiae.
    Yamagami S, Tsuru T.
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2422-6. PubMed ID: 10476812
    [Abstract] [Full Text] [Related]

  • 26. Detection of minor alloantigen-specific cytotoxic T cells after rejection of murine orthotopic corneal allografts: evidence that graft antigens are recognized exclusively via the "indirect pathway".
    Sano Y, Streilein JW, Ksander BR.
    Transplantation; 1999 Oct 15; 68(7):963-70. PubMed ID: 10532535
    [Abstract] [Full Text] [Related]

  • 27. T cell subsets in the immune rejection of murine heterotopic corneal allografts.
    Matoba AY, Peeler JS, Niederkorn JY.
    Invest Ophthalmol Vis Sci; 1986 Aug 15; 27(8):1244-54. PubMed ID: 2942516
    [Abstract] [Full Text] [Related]

  • 28. Immunogenicity and antigenicity of allogeneic amniotic epithelial transplants grafted to the cornea, conjunctiva, and anterior chamber.
    Wang M, Yoshida A, Kawashima H, Ishizaki M, Takahashi H, Hori J.
    Invest Ophthalmol Vis Sci; 2006 Apr 15; 47(4):1522-32. PubMed ID: 16565388
    [Abstract] [Full Text] [Related]

  • 29. [Prolongation of corneal allograft survival in mice with a cyclosporine drug delivery system implant].
    Shi W, Xie L, Wang S.
    Zhonghua Yan Ke Za Zhi; 2002 Aug 15; 38(8):502-5. PubMed ID: 12410993
    [Abstract] [Full Text] [Related]

  • 30. Immunologic mechanisms of corneal allografts reconstituted from cultured allogeneic endothelial cells in an immune-privileged site.
    Hayashi T, Yamagami S, Tanaka K, Yokoo S, Usui T, Amano S, Mizuki N.
    Invest Ophthalmol Vis Sci; 2009 Jul 15; 50(7):3151-8. PubMed ID: 19255161
    [Abstract] [Full Text] [Related]

  • 31. Blockade of CD40-CD154 costimulatory pathway promotes survival of allogeneic corneal transplants.
    Qian Y, Boisgerault F, Benichou G, Dana MR.
    Invest Ophthalmol Vis Sci; 2001 Apr 15; 42(5):987-94. PubMed ID: 11274076
    [Abstract] [Full Text] [Related]

  • 32. Loss and restoration of immune privilege in eyes with corneal neovascularization.
    Dana MR, Streilein JW.
    Invest Ophthalmol Vis Sci; 1996 Nov 15; 37(12):2485-94. PubMed ID: 8933765
    [Abstract] [Full Text] [Related]

  • 33. Role of donor-specific cytotoxic T cells in rejection of corneal allografts in normal and high-risk eyes.
    Ksander BR, Sano Y, Streilein JW.
    Transpl Immunol; 1996 Mar 15; 4(1):49-52. PubMed ID: 8762010
    [Abstract] [Full Text] [Related]

  • 34. CD95 ligand expression on corneal epithelium and endothelium influences the fates of orthotopic and heterotopic corneal allografts in mice.
    Osawa H, Maruyama K, Streilein JW.
    Invest Ophthalmol Vis Sci; 2004 Jun 15; 45(6):1908-15. PubMed ID: 15161857
    [Abstract] [Full Text] [Related]

  • 35. Are corneal cells susceptible to antibody-mediated killing in corneal allograft rejection?
    Hargrave SL, Mayhew E, Hegde S, Niederkorn J.
    Transpl Immunol; 2003 Jun 15; 11(1):79-89. PubMed ID: 12727479
    [Abstract] [Full Text] [Related]

  • 36. New thoughts on the immunology of corneal transplantation.
    Streilein JW.
    Eye (Lond); 2003 Nov 15; 17(8):943-8. PubMed ID: 14631401
    [Abstract] [Full Text] [Related]

  • 37. Enhanced IL-10 and decreased IL-2 production after orthotopic corneal transplantation in mice.
    Hasková Z, Filipec M, Holán V.
    Folia Biol (Praha); 1999 Nov 15; 45(1):21-5. PubMed ID: 10732714
    [Abstract] [Full Text] [Related]

  • 38. Orthotopic corneal transplantation in mice--evidence that the immunogenetic rules of rejection do not apply.
    Sonoda Y, Streilein JW.
    Transplantation; 1992 Oct 15; 54(4):694-704. PubMed ID: 1412761
    [Abstract] [Full Text] [Related]

  • 39. Cytokine expression during orthotopic corneal allograft rejection in mice.
    Sano Y, Osawa H, Sotozono C, Kinoshita S.
    Invest Ophthalmol Vis Sci; 1998 Sep 15; 39(10):1953-7. PubMed ID: 9727419
    [Abstract] [Full Text] [Related]

  • 40. Analysis of primed donor-specific T cells in recipient mice bearing orthotopic corneal allografts.
    Sano Y, Ksander BR, Streilein JW.
    Transplantation; 2000 Nov 15; 70(9):1302-10. PubMed ID: 11087144
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.